Stockholders' Equity - Additional Information (Detail)
|
|
|
|
|
|
|
|
3 Months Ended |
6 Months Ended |
|
|
May 10, 2017
$ / shares
shares
|
May 09, 2017
$ / shares
shares
|
Apr. 19, 2017
VicePresident
$ / shares
shares
|
Apr. 18, 2017
USD ($)
$ / shares
shares
|
Mar. 27, 2017
SeniorVicePresidentChiefFinancialOfficer
$ / shares
shares
|
Feb. 06, 2017
$ / shares
shares
|
Jul. 13, 2015
$ / shares
shares
|
Jun. 30, 2017
USD ($)
$ / shares
shares
|
Jun. 30, 2016
USD ($)
$ / shares
shares
|
Jun. 30, 2017
USD ($)
$ / shares
shares
|
Jun. 30, 2016
USD ($)
$ / shares
shares
|
Dec. 31, 2016
$ / shares
shares
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
$ 0.001
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
200,000,000
|
|
200,000,000
|
|
100,000,000
|
| Proceeds from equity offering, net of expenses | $ |
|
|
|
|
|
|
|
|
|
$ 10,457,000
|
|
|
| Deemed distribution to preferred shareholders, common stock at fair value | $ |
|
|
|
|
|
|
|
$ 3,978,000
|
|
3,978,000
|
|
|
| Compensation expense related to stock options | $ |
|
|
|
|
|
|
|
$ 761,000
|
$ 946,000
|
$ 1,100,000
|
$ 1,800,000
|
|
| Net impact of stock-based compensation expense to earnings per basic share | $ / shares |
|
|
|
|
|
|
|
$ (0.01)
|
$ (0.02)
|
$ (0.02)
|
$ (0.03)
|
|
| Net impact of stock-based compensation expense to earnings per diluted share | $ / shares |
|
|
|
|
|
|
|
$ (0.01)
|
$ (0.02)
|
$ (0.02)
|
$ (0.03)
|
|
| Total unrecognized compensation cost | $ |
|
|
|
|
|
|
|
$ 5,300,000
|
|
$ 5,300,000
|
|
|
| Unrecognized share based compensation cost to be recognized over weighted-average period |
|
|
|
|
|
|
|
|
|
2 years 1 month 6 days
|
|
|
| Reversal of share based compensation expense | $ |
|
|
|
|
|
|
|
|
|
$ 457,000
|
|
|
| Number of newly hired vice presidents | VicePresident |
|
|
1
|
|
|
|
|
|
|
|
|
|
| Number of senior vice president and chief financial officer | SeniorVicePresidentChiefFinancialOfficer |
|
|
|
|
1
|
|
|
|
|
|
|
|
| Outstanding stock options, RSUs and warrants excluded from diluted loss per share |
|
|
|
|
|
|
|
26,792,498
|
15,572,012
|
26,792,498
|
15,572,012
|
|
| Stock Options | Employees |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
|
|
|
|
611,000
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
|
|
|
|
|
$ 1.55
|
|
|
|
|
|
|
| Options expiration period |
|
|
|
|
|
10 years
|
|
|
|
|
|
|
| Stock Options | Existing Employees |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
|
|
|
|
586,000
|
|
|
|
|
|
|
| Stock Options | Existing Employees | Vest on First Anniversary of Award Date |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage |
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
| Stock Options | Existing Employees | Vest on Second Anniversary of Award Date |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage |
|
|
|
|
|
50.00%
|
|
|
|
|
|
|
| Stock Options | New Employees |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share Based Compensation Arrangement By Share Based Payment Award, Vesting Commencement Date |
|
|
|
|
|
Mar. 06, 2018
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Monthly Ratable Award Vesting Period |
|
|
|
|
|
36 months
|
|
|
|
|
|
|
| Options vesting description |
|
|
|
|
|
|
|
|
|
For the 25,000 options awarded to new employees, 25% vest on February 6, 2018 and the remainder vest ratably over the 36-month period, commencing on March 6, 2018.
|
|
|
| Stock Options | New Employees | Vest on February 6, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
|
|
|
|
25,000
|
|
|
|
|
|
|
| Share Based Compensation Arrangement By Share Based Payment Award, Vesting Commencement Date |
|
|
|
|
|
Feb. 06, 2018
|
|
|
|
|
|
|
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage |
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
| Stock Options | Vice Presidents |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
|
400,000
|
|
|
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
|
|
$ 1.17
|
|
|
|
|
|
|
|
|
|
| Options expiration period |
|
|
10 years
|
|
|
|
|
|
|
|
|
|
| Share Based Compensation Arrangement By Share Based Payment Award, Vesting Commencement Date |
|
|
Mar. 13, 2018
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Monthly Ratable Award Vesting Period |
|
|
36 months
|
|
|
|
|
|
|
|
|
|
| Percentage of time based vesting for options |
|
|
75.00%
|
|
|
|
|
|
|
|
|
|
| Stock Options | Vice Presidents | Awards Vesting on March 13, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage |
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
| Non Qualified Stock Options | Non-Employee Directors |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
525,528
|
|
|
|
|
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
$ 1.21
|
|
|
|
|
|
|
|
|
|
|
|
| Options expiration period |
10 years
|
|
|
|
|
|
|
|
|
|
|
|
| Share Based Compensation Arrangement By Share Based Payment Award, Vesting Commencement Date |
Jun. 10, 2017
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Monthly Ratable Award Vesting Period |
12 months
|
|
|
|
|
|
|
|
|
|
|
|
| Non Qualified Stock Options | Senior Vice President and Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
|
|
|
600,000
|
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
|
|
|
|
$ 1.28
|
|
|
|
|
|
|
|
| Options expiration period |
|
|
|
|
10 years
|
|
|
|
|
|
|
|
| Share Based Compensation Arrangement By Share Based Payment Award, Vesting Commencement Date |
|
|
|
|
Mar. 27, 2018
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Monthly Ratable Award Vesting Period |
|
|
|
|
36 months
|
|
|
|
|
|
|
|
| Percentage of time based vesting for options |
|
|
|
|
75.00%
|
|
|
|
|
|
|
|
| Non Qualified Stock Options | Senior Vice President and Chief Financial Officer | Awards Vesting on March 27, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage |
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
|
|
|
|
|
$ 1.55
|
|
|
|
|
|
|
| Granted |
|
|
|
|
|
80,000
|
|
|
|
1,880,176
|
|
|
| Vest in period |
|
|
|
|
|
|
|
|
|
343,511
|
|
|
| Restricted Stock Units (RSUs) | Vest on March 14, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Vest in period |
|
|
|
|
|
30,000
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
|
|
|
|
Mar. 14, 2017
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | Vest on September 14, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Vest in period |
|
|
|
|
|
20,000
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
|
|
|
|
Sep. 14, 2017
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | Vest on May 10, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Vest in period |
|
|
|
|
|
30,000
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
|
|
|
|
May 10, 2018
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | Non-Employee Directors |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
175,176
|
|
|
|
|
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
$ 1.21
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | Non-Employee Directors | Vest on May 10, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
May 10, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | President And Chief Executive Officer |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
|
|
|
|
|
870,000
|
|
|
|
|
|
| Awards valued per share | $ / shares |
|
|
|
|
|
$ 1.55
|
$ 1.64
|
|
|
|
|
|
| Options vesting description |
|
|
|
|
|
(i) one-quarter of the RSUs vest on February 6, 2019, (ii) one-eighth of the RSUs vest on February 6, 2020, (iii) one-eighth of the RSUs vest on February 6, 2021, and (iv) one-half of the RSUs vest upon the achievement of specific interim and annual Company performance criteria
|
|
|
|
|
|
|
| Number of options outstanding |
|
|
|
|
|
|
|
0
|
|
0
|
|
|
| Granted |
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | President And Chief Executive Officer | Vest on February 6, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
|
|
|
|
Feb. 06, 2019
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | President And Chief Executive Officer | Vest on February 6, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
|
|
|
|
Feb. 06, 2020
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) | President And Chief Executive Officer | Vest on February 6, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
|
|
|
|
Feb. 06, 2021
|
|
|
|
|
|
|
| 2002 Stock Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
5 years 4 months 24 days
|
5 years 7 months 6 days
|
5 years 7 months 6 days
|
5 years 8 months 12 days
|
|
| Risk-free interest rate |
|
|
|
|
|
|
|
1.98%
|
1.32%
|
1.98%
|
1.34%
|
|
| Plan expiration date |
|
|
|
|
|
|
|
|
|
May 05, 2019
|
|
|
| Common stock authorized for issuance under the 2002 Plan |
|
|
|
|
|
|
|
15,550,000
|
|
15,550,000
|
|
|
| Common stock issued pursuant to options exercised |
|
|
|
|
|
|
|
|
|
3,903,496
|
|
|
| Options and restricted stock units outstanding |
|
|
|
|
|
|
|
9,395,059
|
|
9,395,059
|
|
|
| Options available for future grants |
|
|
|
|
|
|
|
2,251,445
|
|
2,251,445
|
|
|
| Number of options outstanding |
|
|
|
|
|
|
|
7,440,000
|
|
7,440,000
|
|
6,612,000
|
| 2017 Compensation Plan | Restricted Stock Units (RSUs) | Employees and Consultants |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options granted |
|
500,000
|
|
|
|
|
|
|
|
|
|
|
| Awards valued per share | $ / shares |
|
$ 1.22
|
|
|
|
|
|
|
|
|
|
|
| Options vesting description |
|
(i) one-half of the total grant is subject to time vesting with 50% vesting on May 9, 2018 and the remaining 50% vesting on May 9, 2019, and (ii) one-half of the total grant is subject to specific 2017 and 2018 performance criteria, with vesting upon satisfaction of the applicable performance criteria.
|
|
|
|
|
|
|
|
|
|
|
| Percentage of time based vesting for options |
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
| 2017 Compensation Plan | Restricted Stock Units (RSUs) | Employees and Consultants | Vesting on May 9, 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage |
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
May 09, 2018
|
|
|
|
|
|
|
|
|
|
|
| 2017 Compensation Plan | Restricted Stock Units (RSUs) | Employees and Consultants | Vesting on May 9, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Date |
|
May 09, 2019
|
|
|
|
|
|
|
|
|
|
|
| Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
|
|
|
|
|
|
|
3,925,871
|
|
|
| Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase aggregate unregistered shares of common stock |
|
|
|
3,925,871
|
|
|
|
|
|
|
|
|
| Price per share of unregistered shares of common stock | $ / shares |
|
|
|
$ 1.80
|
|
|
|
|
|
|
|
|
| Conversion of stock, each shares issued |
|
|
|
100
|
|
|
|
|
|
|
|
|
| Stock conversion, price | $ / shares |
|
|
|
$ 1.24
|
|
|
|
|
|
|
|
|
| Warrants exercisable date |
|
|
|
Oct. 18, 2017
|
|
|
|
|
|
|
|
|
| Warrants exercisable of private placement term expiration period |
|
|
|
5 years
|
|
|
|
|
|
|
|
|
| Number of consecutive trading days |
|
|
|
30 days
|
|
|
|
|
|
|
|
|
| Proceeds from equity offering, gross | $ |
|
|
|
$ 10,500,000
|
|
|
|
|
|
$ 10,500,000
|
|
|
| Payments of stock issuance costs | $ |
|
|
|
200,000
|
|
|
|
|
|
|
|
|
| Proceeds from equity offering, net of expenses | $ |
|
|
|
$ 10,300,000
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
The Warrants become exercisable on October 18, 2017 and expire five years after the date of issuance or, if earlier, five business days after the Company delivers notice that the closing price per share of BIOLASE common stock exceeded the Exercise Price for 30 consecutive trading days during the exercise period.
|
|
|
| Deemed distribution to preferred shareholders, common stock at fair value | $ |
|
|
|
|
|
|
|
$ 2,000,000
|
|
$ 2,000,000
|
|
|
| Private Placement | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from equity offering, gross | $ |
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
| Private Placement | Common Stock and Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
5 years
|
|
|
| Risk-free interest rate |
|
|
|
|
|
|
|
|
|
1.90%
|
|
|
| Dividend yield |
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
| Private Placement | Beneficial Conversion |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from equity offering, gross | $ |
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
| Private Placement | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
100,000,000
|
|
|
|
|
|
|
|
|
| Private Placement | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
200,000,000
|
|
|
|
|
|
|
|
|
| Series D Participating Convertible Preferred Stock | Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate unregistered shares |
|
|
|
80,644
|
|
|
|
|
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
| Number of warrants to purchase aggregate unregistered shares of common stock |
|
|
|
3,925,871
|
|
|
|
|
|
|
|
|
| Convertible Preferred Stock | Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from equity offering, gross | $ |
|
|
|
|
|
|
|
|
|
$ 8,200,000
|
|
|